3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Treatment Interruption: new trials by email Literature Review of Treatment Interruption trials Research Report on Treatment Interruption
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy WT-gag-TCR modified T cells, α/6-gag-TCR modified T cells, STI or Drug Holiday - HIV Infections | Phase 1 | Completed | University of Pennsylvania | 2 | 2009-11-01 | 2019-10-10 |
| Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV ZFN modified T cells, Structured Treatment Interruption - HIV, HIV Infections | Phase 1 | Completed | University of Pennsylvania | 12 | 2009-01-01 | 2019-02-08 |
| Immune and Viral Outcomes of HIV-1 Therapy Interruption Treatment interruption/reinitiation schedule - HIV Infections | Phase 1 | Completed | The Wistar Institute | 20 | 2000-09-01 | 2016-02-09 |
HIV Infections (3)
University of Pennsylvania (2) · The Wistar Institute (1)
United States (3)
David Stein, MD (1) · Luis J. Montaner (1) · Pablo Tebas, MD (1)